NHS Breast Screening Programme


Also found in: Acronyms.

NHS Breast Screening Programme

A national programme designed to detect breast cancer at an earlier and more treatable stage, by providing triennial screening mammography and manual breast examination and, if appropriate, needle-core biopsy for all women in the UK aged 50 to 70.
Mentioned in ?
References in periodicals archive ?
The NHS Breast Screening Programme is currently trialling an extension of breast screening up to the age of 73 and when we have the results of this trial, we will know for sure whether screening for older women is beneficial.
Gxtzsche added: "Each year 7,000 women in the UK receive an unnecessary breast cancer diagnosis and unnecessary breast cancer treatment because of overdiagnosis in the NHS breast screening programme.
NHS Breast Screening Programme and Associations of Breast Surgeons at BASO.
The NHS Breast Screening Programme provides free breast screening every three years for all women in the UK aged 50 and over.
Overall, the NHS breast screening programme reported in 2011 that for women whose breast cancers were picked up during screening, 83 out of 100 (83%) per cent are still alive 15 years after their diagnosis.
8Screening appointments "Prompt detection can lead to more effective treatments and the NHS Breast Screening Programme remains an effective tool for women over the age of 50," said Jackie Harris, of Breast Cancer Care (www.
NHS Breast Screening Programme England 2011-12 includes data on those invited for breast screening, coverage, uptake of invitations, outcomes of screening and cancers detected.
Breast screening - the NHS breast screening programme provides free breast screening every three years to detect very early stages of breast cancer.
Experts believe this is, in part, due to tests such as the NHS breast screening programme for women and the PSA test for prostate cancer.
The increasing number of people being diagnosed with cancer is, in part, due to the NHS breast screening programme and the PSA test for prostate cancer.